Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -1.366M
March 31, 2026 2.147M
December 31, 2025 -19.42M
September 30, 2025 5.283M
June 30, 2025 25.12M
March 31, 2025 35.35M
December 31, 2024 -19.50M
September 30, 2024 -35.24M
June 30, 2024 -20.67M
March 31, 2024 16.19M
December 31, 2023 22.40M
September 30, 2023 31.84M
June 30, 2023 10.17M
March 31, 2023 9.933M
December 31, 2022 -46.72M
September 30, 2022 -101.85M
June 30, 2022 -5.271M
March 31, 2022 -2.539M
December 31, 2021 -4.689M
September 30, 2021 -3.273M
June 30, 2021 -3.524M
March 31, 2021 -2.159M
December 31, 2020 -2.145M
September 30, 2020 -2.049M
June 30, 2020 -2.025M
Date Value
March 31, 2020 -2.185M
December 31, 2019 -2.979M
September 30, 2019 -2.568M
June 30, 2019 -2.398M
March 31, 2019 -2.233M
December 31, 2018 -0.524M
September 30, 2018 -0.452M
June 30, 2018 -0.304M
March 31, 2018 -0.965M
December 31, 2017 -0.077M
September 30, 2017 -0.345M
June 30, 2017 -0.311M
March 31, 2017 -0.313M
December 31, 2016 -0.561M
September 30, 2016 -0.67M
June 30, 2016 -0.968M
March 31, 2016 -1.006M
December 31, 2015 -0.762M
September 30, 2015 -0.582M
June 30, 2015 -0.373M
March 31, 2015 -0.326M
December 31, 2014 -1.605M
September 30, 2014 -0.248M
June 30, 2014 -0.787M
March 31, 2014 -1.414M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. -26.60M
Stryker Corp. -639.00M
Zimmer Biomet Holdings, Inc. -190.80M
Enovis Corp. -45.01M
Edwards Lifesciences Corp. -193.20M